Further analysis of clinical data from 57 additional anti‐MDA5+ DM inpatients corroborated these findings, revealing a general decrease in NK and T cell counts, including CD4 T and CD8 T cells (Figure 1I), aligning with previous studies.9, 19. This evidence concerns the gene IFIH1 and dermatomyositis.